Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Hypersensitivity Reaction

  Free Subscription


Articles published in J Am Acad Dermatol

Retrieve available abstracts of 95 articles:
HTML format



Single Articles


    November 2022
  1. XIONG M, Warshaw EM
    Popular Sunscreens Marketed to Individuals with Skin of Color: Cost, Marketing Claims, and Allergenic Ingredients.
    J Am Acad Dermatol. 2022 Nov 14. pii: S0190-9622(22)03006.
    PubMed     Abstract available


  2. HEYMANN WR
    Eczema knowledge gaps: Patching things up.
    J Am Acad Dermatol. 2022;87:987-988.
    PubMed    


  3. SILVERBERG JI, Patel N, Warshaw EM, DeKoven JG, et al
    Hand and foot dermatitis in patients referred for patch testing: Analysis of North American Contact Dermatitis Group Data, 2001-2018.
    J Am Acad Dermatol. 2022;87:1049-1059.
    PubMed     Abstract available


  4. WARSHAW EM, Xiong M, Atwater AR, DeKoven JG, et al
    Patch testing with glucosides: The North American Contact Dermatitis Group experience, 2009-2018.
    J Am Acad Dermatol. 2022;87:1033-1041.
    PubMed     Abstract available


  5. JIANG Q, Ruan JW, Niu MM, Fan GZ, et al
    A predictive system for Henoch-Schonlein purpura nephritis established by multivariate analysis plus nomogram model in Chinese hospitalized children: A retrospective cohort study.
    J Am Acad Dermatol. 2022;87:1137-1139.
    PubMed    


  6. WARSHAW EM, Ruggiero JL, DeKoven JG, Pratt MD, et al
    Patch testing with ammonium persulfate: The North American Contact Dermatitis Group Experience, 2015-2018.
    J Am Acad Dermatol. 2022;87:1014-1023.
    PubMed     Abstract available


  7. LISZEWSKI W, Zaidi AJ, Fournier E, Scheman A, et al
    Review of aluminum, paraben, and sulfate product disclaimers on personal care products.
    J Am Acad Dermatol. 2022;87:1081-1086.
    PubMed     Abstract available


  8. NORRESLET LB, Edslev SM, Clausen ML, Flachs EM, et al
    Hand eczema and temporal variation of Staphylococcus aureus clonal complexes: A prospective observational study.
    J Am Acad Dermatol. 2022;87:1006-1013.
    PubMed     Abstract available


  9. RUTHERFORD A, Glass DA 2nd, Savory S
    Dermatology in orbit: Anticipating skin care requirements in the space age.
    J Am Acad Dermatol. 2022;87:1223-1224.
    PubMed    


    October 2022
  10. GORI N, Chiricozzi A, Peris K
    Response to Narla S et al.'s "Management of inadequate response and adverse effects to dupilumab in atopic dermatitis"."
    J Am Acad Dermatol. 2022 Oct 22. pii: S0190-9622(22)02967.
    PubMed    


  11. VANLERBERGHE J, Dezoteux F, Martin C, Jachiet M, et al
    Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort.
    J Am Acad Dermatol. 2022 Oct 21. pii: S0190-9622(22)02960.
    PubMed    


  12. SMITH B, Collier MR, Devjani S, Han G, et al
    Association between atopic dermatitis and thyroid disease among United States adults in the 2001-2006 National Health and Nutrition Examination Survey.
    J Am Acad Dermatol. 2022 Oct 13. pii: S0190-9622(22)02888.
    PubMed    


  13. SLOAN B
    This month in JAAD Case Reports: October 2022. Pseudochromhidrosis and Dupilumab.
    J Am Acad Dermatol. 2022;87:750.
    PubMed    


    September 2022
  14. YANG AF, San Chun K, Yu L, Walter JR, et al
    Validation of a hand-mounted wearable sensor for scratching movements in adults with atopic dermatitis.
    J Am Acad Dermatol. 2022 Sep 22. pii: S0190-9622(22)02775.
    PubMed    


  15. FAN R, Leasure AC, Damsky W, Cohen JM, et al
    Alcohol use disorder among adults with atopic dermatitis: A case-control study in the All of Us research program.
    J Am Acad Dermatol. 2022 Sep 21. pii: S0190-9622(22)02739.
    PubMed    


  16. BLAUVELT A, Szepietowski JC, Papp K, Simpson EL, et al
    Itch-Free State in Patients With Atopic Dermatitis Treated With Ruxolitinib Cream: Pooled Analysis From Two Randomized Phase 3 Studies.
    J Am Acad Dermatol. 2022 Sep 13. pii: S0190-9622(22)02688.
    PubMed    


  17. HADAVAND MA, Kaffenberger B, Cartron AM, Trinidad JCL, et al
    Clinical presentation and management of atypical and recalcitrant acute generalized exanthematous pustulosis.
    J Am Acad Dermatol. 2022;87:632-639.
    PubMed     Abstract available


    August 2022
  18. JELOUSI S, Murase EM, Bai H, Botto NB, et al
    First, Do No Harm: The Urgent Need for Comprehensive Clinical Guidelines for Diagnostic Testing of Recalcitrant "Atopic Dermatitis".
    J Am Acad Dermatol. 2022 Aug 22. pii: S0190-9622(22)02404.
    PubMed    


  19. KAMATH S
    JAAD Game Changers: Longitudinal atopic dermatitis control and persistence vary with timing of disease onset in children: A cohort study.
    J Am Acad Dermatol. 2022 Aug 3. pii: S0190-9622(22)02421.
    PubMed    


  20. MAGYARI A, Ye M, Margolis DJ, McCulloch CE, et al
    Adult atopic eczema and the risk of dementia: A population-based cohort study.
    J Am Acad Dermatol. 2022;87:314-322.
    PubMed     Abstract available


  21. ADELANWA A, Yousaf A, Fang W, Kolodney MS, et al
    Common filaggrin gene loss-of-function variants are associated with skin cancer risk.
    J Am Acad Dermatol. 2022;87:458-460.
    PubMed    


  22. FOSCHI CM, Tam I, Schalock PC, Yu J, et al
    Patch testing results in skin of color: A retrospective review from the Massachusetts General Hospital contact dermatitis clinic.
    J Am Acad Dermatol. 2022;87:452-454.
    PubMed    


  23. HAN JJ, Creadore A, Seminario-Vidal L, Micheletti R, et al
    Medical management of Stevens-Johnson syndrome/toxic epidermal necrolysis among North American dermatologists.
    J Am Acad Dermatol. 2022;87:429-431.
    PubMed    


    July 2022
  24. GEIER J, Schubert S, Buhl T
    Glutaraldehyde sensitization does not explain reactivity to alkyl polyglucosides in personal care products: results from review of a large contact allergy database.
    J Am Acad Dermatol. 2022 Jul 20. pii: S0190-9622(22)02399.
    PubMed    


  25. BLAUVELT A, Langley RG, Lacour JP, Toth D, et al
    Long-term 2-Year Safety and Efficacy of Tralokinumab in Adults with Moderate-to-severe Atopic Dermatitis: Interim Analysis of the ECZTEND Open-label Extension Trial.
    J Am Acad Dermatol. 2022 Jul 18. pii: S0190-9622(22)02345.
    PubMed     Abstract available


  26. BRONIN A
    Emollients in infancy to prevent atopic dermatitis: A systematic review and meta-analysis.
    J Am Acad Dermatol. 2022 Jul 14. pii: S0190-9622(22)02263.
    PubMed    


  27. O'CONNELL KA, Kim LS, Szeto MD, Sivesind T, et al
    From the Cochrane Library: Phototherapy for atopic eczema.
    J Am Acad Dermatol. 2022;87:e23-e26.
    PubMed    


    June 2022
  28. SHETH AP, Blumstein AJ, Rangel S, Jackson KL, et al
    Three-Question Skindex-Mini Measures Quality of Life in Children with Atopic Dermatitis.
    J Am Acad Dermatol. 2022 Jun 23. pii: S0190-9622(22)02215.
    PubMed    


  29. MENDES-BASTOS P, Ladizinski B, Guttman-Yassky E, Jiang P, et al
    Characterization of acne associated with upadacitinib treatment in patients with moderate-to-severe atopic dermatitis: a post hoc integrated analysis of three phase 3 randomized, double-blind, placebo-controlled trials.
    J Am Acad Dermatol. 2022 Jun 14. pii: S0190-9622(22)00996.
    PubMed     Abstract available


  30. MOSCA M, Hadeler E, Hong J, Hakimi M, et al
    A cross-sectional study of ethnic and racial disparities in pediatric atopic dermatitis clinical trials.
    J Am Acad Dermatol. 2022 Jun 8. pii: S0190-9622(22)00908.
    PubMed    


  31. AMORNRUK N, Siranart N, Sittiwattanawong P, Kueanjinda P, et al
    The immediate patch test reaction to fragrance in patients with allergic contact dermatitis to fragrance: A prospective study.
    J Am Acad Dermatol. 2022 Jun 8. pii: S0190-9622(22)00897.
    PubMed     Abstract available


  32. AO S, Gao X, Zhan J, Ai L, et al
    Inhibition of tumor necrosis factor improves conventional steroid therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis in a cohort of patients.
    J Am Acad Dermatol. 2022;86:1236-1245.
    PubMed     Abstract available


    May 2022
  33. CHATRATH S, Lei D, Yousaf M, Chavda R, et al
    Longitudinal course and predictors of depressive symptoms in atopic dermatitis.
    J Am Acad Dermatol. 2022 May 9. pii: S0190-9622(22)00792.
    PubMed     Abstract available


  34. DE DR, Seivright J, Yee D, Hsiao JL, et al
    Readability, quality, and timeliness of patient online health resources for urticaria.
    J Am Acad Dermatol. 2022;86:1182-1185.
    PubMed    


    April 2022
  35. SILVERBERG JI, Rangel SM, Sheth A, Blumstein A, et al
    Single-question parent-reported global atopic dermatitis severity: a valid instrument in children.
    J Am Acad Dermatol. 2022 Apr 27. pii: S0190-9622(22)00706.
    PubMed    


  36. RICK JW, Morgan A, De DR, Hsiao JL, et al
    Allergens and Marketing Claims of The Most Popular Baby Moisturizers: A Product Analysis.
    J Am Acad Dermatol. 2022 Apr 26. pii: S0190-9622(22)00700.
    PubMed    


  37. SHI VY, Bhutani T, Fonacier L, Deleuran M, et al
    Phase 3 Efficacy and Safety of Abrocitinib in Adults with Moderate-to-Severe Atopic Dermatitis After Switching from Dupilumab (JADE EXTEND).
    J Am Acad Dermatol. 2022 Apr 16. pii: S0190-9622(22)00608.
    PubMed     Abstract available


  38. JELOUSI S, Butler DC
    Sleep Disturbances in Older Adults with Pruritic Eruptions: Implications Across Inconsistent Literature and a Commentary on "Association of Sleep Disturbances with Geriatric Age in Atopic Dermatitis Patients".
    J Am Acad Dermatol. 2022 Apr 11. pii: S0190-9622(22)00605.
    PubMed    


  39. HEYMANN WR
    More than Mycoplasma-induced rash and mucositis: The potential role of Mycoplasma pneumoniae in Stevens-Johnson syndrome/toxic epidermal necrolysis.
    J Am Acad Dermatol. 2022;86:746-747.
    PubMed    


  40. SILVERBERG JI, Hou A, Warshaw EM, DeKoven JG, et al
    Age-related differences in patch testing results among children: Analysis of North American Contact Dermatitis Group Data, 2001-2018.
    J Am Acad Dermatol. 2022;86:818-826.
    PubMed     Abstract available


  41. LIEW YCC, Choo KJL, Oh CC, Pang SM, et al
    Mycoplasma-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: Case-control analysis of a cohort managed in a specialized center.
    J Am Acad Dermatol. 2022;86:811-817.
    PubMed     Abstract available


  42. DEKOVEN JG, DeKoven BM, Warshaw EM, Mathias CGT, et al
    Occupational contact dermatitis: Retrospective analysis of North American Contact Dermatitis Group Data, 2001 to 2016.
    J Am Acad Dermatol. 2022;86:782-790.
    PubMed     Abstract available


  43. KOLITZ E, Karbhari N, Son T, Dominguez AR, et al
    Validation of two predictive models designed to aid clinicians in identifying Stevens-Johnson syndrome/toxic epidermal necrolysis: A single institution retrospective review.
    J Am Acad Dermatol. 2022;86:960-962.
    PubMed    


  44. UGWU N, Cheraghlou S, Feng H, Cohen JM, et al
    Characterization of outpatient visits and treatments for urticaria in the United States adult population between 1998 and 2016.
    J Am Acad Dermatol. 2022;86:936-938.
    PubMed    


    March 2022
  45. CHEN J, Cheng J, Yang H, Tu W, et al
    The Efficacy and Safety of Janus Kinase Inhibitors in Patients with Atopic Dermatitis: A Systematic Review and Meta-analysis.
    J Am Acad Dermatol. 2022 Mar 28. pii: S0190-9622(22)00529.
    PubMed    


  46. FAN R, Leasure AC, Damsky W, Cohen JM, et al
    Association of Atopic Dermatitis with Attention Deficit Hyperactivity Disorder among US Adults in the All of Us Research Program: A Case-Control Study.
    J Am Acad Dermatol. 2022 Mar 10. pii: S0190-9622(22)00395.
    PubMed    


  47. JU T, Labib A, Does AV, Yosipovitch G, et al
    Topical JAK-STAT inhibitor tofacitinib is effective in reducing non-atopic dermatitis chronic itch: a case series.
    J Am Acad Dermatol. 2022 Mar 9. pii: S0190-9622(22)00393.
    PubMed    


  48. LIM JH, Lew BL, Sim WY, Kwon SH, et al
    Incidence of childhood-onset vitiligo and increased risk of atopic dermatitis, autoimmune diseases, and psoriasis: A nationwide population-based study.
    J Am Acad Dermatol. 2022 Mar 8. pii: S0190-9622(22)00390.
    PubMed    


  49. KANTOR J
    This Month in JAAD International: May 2022: Atopic dermatitis severity and mental health.
    J Am Acad Dermatol. 2022 Mar 5. pii: S0190-9622(22)00368.
    PubMed    


  50. SREEKANTASWAMY SA, Tully J, Edelman LS, Supiano MA, et al
    The Underrepresentation of Older Adults in Clinical Trials for JAK Inhibitors to Treat Atopic Dermatitis.
    J Am Acad Dermatol. 2022 Mar 1. pii: S0190-9622(22)00365.
    PubMed    


  51. YANG CY, Chen SP, Wei JC
    Correspondence to "Association between psoriasis and asthma among United States adults in the 2009-2014 national health and nutrition examination survey".
    J Am Acad Dermatol. 2022;86:e117.
    PubMed    


  52. MARTIN A, Thatiparthi A, Liu J, Ge S, et al
    Reply to "Correspondence to 'Association between psoriasis and asthma among United States adults in the 2009-2014 National Health and Nutrition Examination Survey'".
    J Am Acad Dermatol. 2022;86:e119-e120.
    PubMed    


  53. MARTIN A, Thatiparthi A, Liu J, Ge S, et al
    Association between psoriasis and asthma among United States adults in the 2009-2014 National Health and Nutrition Examination Survey.
    J Am Acad Dermatol. 2022;86:709-712.
    PubMed    


  54. WONGVIBULSIN S, Pahalyants V, Kalinich M, Murphy W, et al
    Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune-checkpoint inhibitors: A United States population-level analysis.
    J Am Acad Dermatol. 2022;86:563-572.
    PubMed     Abstract available


  55. PATEL S, Cadwell JB, Lambert WC
    Effect of older age on complications and mortality in inpatients with Stevens-Johnson syndrome or toxic epidermal necrolysis.
    J Am Acad Dermatol. 2022;86:665-667.
    PubMed    


    February 2022
  56. ZHENG DX, Cwalina TB, Jella TK, Cullison CR, et al
    Financial insecurity among U.S. children with atopic dermatitis.
    J Am Acad Dermatol. 2022 Feb 28. pii: S0190-9622(22)00362.
    PubMed    


  57. DEL POZO DV, Zhu Y, Mitra N, Hoffstad OJ, et al
    The risk of atopic comorbidities and atopic march progression among Black and White children with mild to moderate atopic dermatitis: a cross-sectional study.
    J Am Acad Dermatol. 2022 Feb 19. pii: S0190-9622(22)00334.
    PubMed    


  58. CHOVATIYA R, Silverberg JI
    Evaluating the Longitudinal Course of Atopic Dermatitis: a review of the literature.
    J Am Acad Dermatol. 2022 Feb 9. pii: S0190-9622(22)00253.
    PubMed    


  59. THERIANOU A, Vincenzi C, Tosti A
    How safe is prescribing oral minoxidil in patients allergic to topical minoxidil?
    J Am Acad Dermatol. 2022;86:429-431.
    PubMed    


    January 2022
  60. DAVIS DMR, Drucker AM, Alikhan A, Bercovitch L, et al
    AAD Guidelines: awareness of comorbidities associated with atopic dermatitis in adults.
    J Am Acad Dermatol. 2022 Jan 24. pii: S0190-9622(22)00080.
    PubMed     Abstract available


  61. PALLER AS, Guttman-Yassky E, Schuttelaar MLA, Irvine AD, et al
    Disease Characteristics, Comorbidities, Treatment Patterns and Quality of Life Impact in Children <12 Years Old with Atopic Dermatitis: Interim Results from the PEDISTAD Real-World Registry.
    J Am Acad Dermatol. 2022 Jan 23. pii: S0190-9622(22)00092.
    PubMed    


    December 2021
  62. GAU SY
    Antibiotic Exposures Could Lead to Overestimation of Incident Outcomes-a Commentary on "Prevalence of type 2 inflammatory diseases in pediatric patients with atopic dermatitis: real-world evidence."
    J Am Acad Dermatol. 2021 Dec 20. pii: S0190-9622(21)02992.
    PubMed    


  63. DAL BELLO G, Maurelli M, Schena D, Gisondi P, et al
    Variations of symptoms of atopic dermatitis and psoriasis in relation to menstrual cycle.
    J Am Acad Dermatol. 2021 Dec 14. pii: S0190-9622(21)02975.
    PubMed    


  64. ATWATER AR, Bembry R, Liu B, Warshaw EM, et al
    Medical Adhesive Allergens: Retrospective Analysis of Cross-Sectional Data from the North American Contact Dermatitis Group, 2001-2018.
    J Am Acad Dermatol. 2021 Dec 4. pii: S0190-9622(21)02927.
    PubMed     Abstract available


  65. COIFFARD LJM, Couteau C
    Are alkyl glucosides really allergens?
    J Am Acad Dermatol. 2021;85:e355.
    PubMed    


  66. MUFTI A, Sachdeva M, Kim P, Rahat S, et al
    A systematic review of eczematous eruptions in patients receiving biologic therapy.
    J Am Acad Dermatol. 2021;85:1630-1635.
    PubMed    


  67. RINOLDI PO, Bronz G, Ferrarini A, Mangas C, et al
    Acute hemorrhagic edema: Uncommon features.
    J Am Acad Dermatol. 2021;85:1620-1621.
    PubMed    


  68. AL MUSALHI BH, Al Kamzari A, Al Kindi F, Al Abrawi S, et al
    Clinical spectrum of childhood-onset hypocomplementemic urticarial vasculitis in Oman: A retrospective multicenter study.
    J Am Acad Dermatol. 2021;85:1617-1620.
    PubMed    


  69. HIROTSU KE, Rana J, Wang JY, Raghavan SS, et al
    Clinicopathologic characterization of enfortumab vedotin-associated cutaneous toxicity in patients with urothelial carcinoma.
    J Am Acad Dermatol. 2021;85:1610-1611.
    PubMed    


  70. MCCORMACK L, Thompson LL, Chang MS, Polyakov N, et al
    Cutaneous adverse events to immune checkpoint inhibitors in pediatric populations: A retrospective cohort study.
    J Am Acad Dermatol. 2021;85:1587-1589.
    PubMed    


  71. BETTUZZI T, Ingen-Housz-Oro S, Purtillo CC, Le Cleach L, et al
    Changing spectrum of suspected drugs of epidermal necrolysis: A World Health Organization pharmacovigilance database analysis from 1997-2020.
    J Am Acad Dermatol. 2021;85:1581-1584.
    PubMed    


  72. WARSHAW EM, Schlarbaum JP, Silverberg JI, DeKoven JG, et al
    Contact dermatitis to personal care products is increasing (but different!) in males and females: North American Contact Dermatitis Group data, 1996-2016.
    J Am Acad Dermatol. 2021;85:1446-1455.
    PubMed     Abstract available


  73. CHOVATIYA R, Silverberg JI
    Association of herpes zoster and chronic inflammatory skin disease in US inpatients.
    J Am Acad Dermatol. 2021;85:1437-1445.
    PubMed     Abstract available


    November 2021
  74. GUO L, Bai H, Botto N, Woodruff CM, et al
    Allergens and Marketing Claims in Commercial Hand Sanitizers: A Cross-Sectional Study.
    J Am Acad Dermatol. 2021 Nov 24. pii: S0190-9622(21)02895.
    PubMed    


  75. ROH YS, Huang AH, Sutaria N, Choi U, et al
    Real-world comorbidities of atopic dermatitis in the U.S. adult ambulatory population.
    J Am Acad Dermatol. 2021 Nov 17. pii: S0190-9622(21)02838.
    PubMed     Abstract available


  76. CHOVATIYA R, Silverberg JI
    DESCRIBE-AD: A Novel Classification Framework for Atopic Dermatitis.
    J Am Acad Dermatol. 2021 Nov 10. pii: S0190-9622(21)02795.
    PubMed     Abstract available


  77. KAMEL K, Militello M, Sivesind TE, Szeto MD, et al
    From the Cochrane Library: Psychologic and educational interventions for atopic eczema in children.
    J Am Acad Dermatol. 2021;85:e309-e311.
    PubMed    


  78. CHENG HM, Tey HL
    Response to: Momen et al's "Discriminating minor and major forms of drug reaction with eosinophilia and systemic symptoms: Facial edema aligns to the severe phenotype".
    J Am Acad Dermatol. 2021;85:e303-e304.
    PubMed    


  79. CHERAGHLOU S, Watsky KL, Cohen JM
    Utilization, cost, and provider trends in patch testing among Medicare beneficiaries in the United States from 2012 to 2017.
    J Am Acad Dermatol. 2021;85:1218-1226.
    PubMed     Abstract available


    October 2021
  80. PALLER AS, Mina-Osorio P, Vekeman F, Boklage S, et al
    Prevalence of type 2 inflammatory diseases in pediatric patients with atopic dermatitis: real-world evidence.
    J Am Acad Dermatol. 2021 Oct 28. pii: S0190-9622(21)02720.
    PubMed     Abstract available


  81. SAEKI H, Ito K, Yokota D, Tsubouchi H, et al
    Difamilast ointment in adult patients with atopic dermatitis: A phase 3 randomized double-blind vehicle-controlled trial.
    J Am Acad Dermatol. 2021 Oct 25. pii: S0190-9622(21)02682.
    PubMed     Abstract available


  82. GHAFARI G, Liszewski W
    Comparison of the formulation and allergenic potential of "clean" and traditional shampoos.
    J Am Acad Dermatol. 2021 Oct 22. pii: S0190-9622(21)02684.
    PubMed    


  83. KAUPPI S, Jokelainen J, Timonen M, Tasanen K, et al
    Atopic dermatitis and the risk of eating disorders: a population-based cohort study.
    J Am Acad Dermatol. 2021 Oct 21. pii: S0190-9622(21)02674.
    PubMed    


  84. RAKITA U, Kaundinya T, Silverberg JI
    Lack of association between atopic dermatitis severity and worsening during pregnancy: a cross-sectional study.
    J Am Acad Dermatol. 2021 Oct 7. pii: S0190-9622(21)02585.
    PubMed    


  85. WU JJ, Martin A, Liu J, Thatiparthi A, et al
    The risk of COVID-19 infection in patients with atopic dermatitis - a retrospective cohort study.
    J Am Acad Dermatol. 2021 Oct 6. pii: S0190-9622(21)02578.
    PubMed    


  86. QUACH HT, Johnson DB, LeBoeuf NR, Zwerner JP, et al
    Cutaneous adverse events caused by immune checkpoint inhibitors.
    J Am Acad Dermatol. 2021;85:956-966.
    PubMed     Abstract available


  87. DUPLISEA MJ, Roberson ML, Chrisco L, Strassle PD, et al
    Performance of ABCD-10 and SCORTEN mortality prediction models in a cohort of patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    J Am Acad Dermatol. 2021;85:873-877.
    PubMed     Abstract available


  88. CHOUDHARY R, Vinay K, Srivastava N, Bishnoi A, et al
    Clinical, biochemical, and serologic predictors of drug reaction with eosinophilia and systemic symptoms syndrome: A prospective case-control study.
    J Am Acad Dermatol. 2021;85:901-909.
    PubMed     Abstract available


  89. SACHDEVA M, Mufti A, Kim P, Maliyar K, et al
    Biologic treatment in pediatric Stevens-Johnson syndrome/toxic epidermal necrolysis: A systematic review.
    J Am Acad Dermatol. 2021;85:1011-1013.
    PubMed    


    September 2021
  90. SILVERBERG JI, Hou A, Warshaw EM, Maibach HI, et al
    Prevalence and Trend of Allergen Sensitization in Patients with a Diagnosis of Seborrheic Dermatitis After Patch Testing, North American Contact Dermatitis Group Data, 2001-2016.
    J Am Acad Dermatol. 2021 Sep 25. pii: S0190-9622(21)02522.
    PubMed    


  91. MOLOGOUSIS M, Goldminz AM
    References for Common Contact Allergens Present in Prescription Topical Corticosteroids.
    J Am Acad Dermatol. 2021 Sep 24. pii: S0190-9622(21)02490.
    PubMed    


  92. HUGHES ME, Aralis H, Bruhn KW, Cotliar J, et al
    A reliability study using Network-Oriented Research Assistant to evaluate the use of digital photographs in the assessment of atopic dermatitis.
    J Am Acad Dermatol. 2021;85:725-726.
    PubMed    


  93. WALDMAN RA, DeWane ME, Sloan SB, King B, et al
    Dupilumab ocular surface disease occurs predominantly in patients receiving dupilumab for atopic dermatitis: A multi-institution retrospective chart review.
    J Am Acad Dermatol. 2021;85:735-736.
    PubMed    


  94. MOMEN SE, Diaz-Cano S, Walsh S, Creamer D, et al
    Discriminating minor and major forms of drug reaction with eosinophilia and systemic symptoms: Facial edema aligns to the severe phenotype.
    J Am Acad Dermatol. 2021;85:645-652.
    PubMed     Abstract available


    September 2020
  95. LYTVYN Y, Mufti A, Sachdeva M, Maliyar K, et al
    Stevens Johnson Syndrome and Toxic Epidermal Necrolysis Reactions to BRAF and MEK Inhibitors in Patients with Melanoma: A Systematic Review.
    J Am Acad Dermatol. 2020 Sep 11. pii: S0190-9622(20)32613.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: